Skip to Content

MYLAN 2035 MYLAN 2035 (Topiramate (sprinkle) 15 mg)

This pill with imprint "MYLAN 2035 MYLAN 2035" is Pink, Capsule-shape and has been identified as Topiramate (sprinkle) 15 mg. It is manufactured by Mylan Pharmaceuticals Inc..

Topiramate is used in the treatment of obesity; migraine prevention; fibromyalgia; bipolar disorder; crohn's disease (and more), and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 15 mg is not a controlled substance under the Controlled Substance Act (CSA).

Topiramate (sprinkle) 15 mg MYLAN 2035 MYLAN 2035
Discount Card Promo
Topiramate (sprinkle)
MYLAN 2035 MYLAN 2035
15 mg
Prescription only
Drug Class:
Carbonic anhydrase inhibitor anticonvulsants
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Mylan Pharmaceuticals Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.